Guardant Health, Inc. (GH)
Last updated: 2026-10-21 22:28:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Guardant Health, Inc. (GH) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $166.69, with a market capitalization of $21.19B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $66.59 to $191.05. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$21.19B | |
$162.29 | |
$191.05 | |
$15.81 | |
$162.59 | |
1.60M | |
1.94M | |
-- | |
$191.05 | |
$66.59 | |
-- | |
-- |
Guardant Health, Inc. (GH) After-Hours Stock Price
Guardant Health, Inc. (GH) is trading at $167.38 in after-hours trading as of 2026-10-21 22:01:00, up 2.94% ($4.78) from the regular-session close of $162.59.
After-hours trading shows how investors are pricing GH after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Guardant Health, Inc. (GH) 7-Day Stock Price Change
Over the past seven days, Guardant Health, Inc. (GH) moved from $162.79 to $166.69, representing a gain of 2.40% ($3.90).
The stock traded between $155.00 and $171.11 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.52 million shares, down versus the previous seven-day period, indicating lower trading activity.
GH 52-Week Price Position
Position in Range: 80.4%
GH is currently trading at $166.69, placing it 80.4% of the way from its 52-week low of $66.59 to its 52-week high of $191.05. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Guardant Health, Inc. (GH)?
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Guardant Health, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 2506 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Guardant Health, Inc. (GH) Stock on MEXC
Eligible investors can buy real shares of Guardant Health, Inc. (GH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Guardant Health, Inc. (GH) stock price today?
2.Is GH stock going up or down today?
3.What is GH pre-market price?
4.What is GH after-hours price?
5.Is GH stock trading now?
6.Where does GH sit relative to its 52-week high and low?
7.What sector is Guardant Health, Inc. in?
8.What is Guardant Health, Inc.'s market capitalization and where is it listed?
9.How is GH valued in terms of P/E ratio and EPS?
10.Does Guardant Health, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
GH Stock Calculator
Estimate the value between GH shares and USD.
GH Shares to USD
1.00 GH shares = 166.693 USD
Calculations are estimates based on the latest available price and are for reference only.


